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terizedby similarissues,but with a differentmagnitude.Obesity,type2 diabetes,and
peripheralvasculardisease,independentpredictorsof centralvenouscatheteruse,are
growingproblemsglobally,which couldlead to moredifficultiesin nativearteriovenous
fistulaplacementand survival.Creationof dedicateddialysisaccessteams,inc1udinga
vascularaccesscoordinator,is a fundamentalstep in improvingvascularaccesscare;
however,it might not be sufficient.The possibilitythat factorsother than patient
characteristicsandsurgicalskillsareimportantin determiningoutcomesis likely;it might
explainapparentcontradictionsof end-stagerenal disease(ESRD) practices(kidney
transplant,peritonealdialysis,patternsof vascularaccessuse in hemodialysis),where
somecountriesexcelin oneareaandscorepoorlyin another.We areonthesamepath,but
we havea lortgwayto go.
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Large differencesin the approachto vascular
accessexistbetweenEurope, Canada,and the United
States,evenafteradjustmentfor patientcharacteristics.1
However,strikingdifferencesalsoexistwithin different
Europeancountries,as well as amongdifferentend-
stagerenal disease(ESRD) networksin the United
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States.In theUnitedStatesNationalSurveillancereport
for 2002,Finelli et a12reportedthat41.6%of patients
receiveddialysisthroughanarteriovenousgraft(AVG),
32.7% through an arteriovenousfistula (AVF), and
26.3%throughatemporaryorpermanentcentralvenous
catheter(CVC). Among the 18 U.S. ESRD networks
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designatedby the Centersfor MedicareandMedicaid
Services(CMS), use of fistulasrangedfrom 25.4 to
53.4%.
In 2002,the first seriesof datawaspublishedon
vascularaccessfromtheDialysisOutcomesandPractice




countries (France, Germany, Italy, Spain, and the
United Kingdom [UK.]). Facilitiesand patientswere
se1ectedto providenationaliyrepresentativesamplesof
the HD populationin eachcountry.The samedata
coHectionprotocolwasusedin ali countriesallowinga
directcomparisonofoutcomesacrosscountriesandtypes
of facilities.In Europe,A VF accountedfor 80%of aH
accesses,with 10%of patientsusinggrafts.High AVF
usewasseenin aHfiveEuropeancountries,rangingfrom
67%in theU.K. to 90%in Italy.In contrast,graftswere
the predominantaccesstype in the United States,
comprising58%of aHaccesses,with only 24%of US.
patientsusing an A VF. Catheterusewas 17%in the
United Statescomparedwith 8%in Europe.The main
finding of the studywas that the facilitiespreferences





teristics,Fig. 1 iHustratesa representativeUS. patient
with extremedeteriorationof vesse1s,notuncommonin
U.S. vascularaccessclinicsand veryrarein European
renalunits.US. patientsweremorelike1ydiabetic(46%
versus22% of the population),affectedby peripheral
vasculardisease(23%versus19%),with aheavierhistory
of anginapectoris(37%versus25%).In addition,US.
patientshad a higher numberof females(47%versus
43%),a highermeanbodymassindex(BMIj 25.1±5.9
versus24.1±4.7 kg/m2), anda shorterdialysisvintage
(3.4versus5.1 yearson HD). Strikingly,the-adjusted
oddsratio (OR) for the probabilityof havingan A VF
versusA VG amongprevalentHD patientsin Europe
andtheUnited Stateswas21 (p <0.0001).Converse1y,
significantlyunfavorableORs (indicatingthatthecova-




(OR 0.80),age(foreverylO yearsolder,OR 0.89),BMI
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Figure 1 Patient referred for vascular access surgery,
underscoringthe difficultiesthat might be encounteredin
the US patientpopulation.This patienthad alreadyunder-
gonemultipleproceduresandatthe timeof referralshe was
dialyzedwith two single-Iumentunneledcatheters.
over,AVG usefell by 50%in the United Statesfrom
58%usein 1996to 28%by2007.Catheteruserose1.5-
to 3-fold amongprevalentpatients,evenif nondiabetic.
Furthermore,58 to 73% of incident patientsused a
catheterfor theinitiationofHD in fivecountriesdespite
60to 79%ofpatientshavingbeenseenbyanephrologist
more than 4 monthsprior to ESRD. Patientswere
significantlylesslike1yto startdialysiswith apermanent
vascularaccess(VA) if treatedin a facility that had a
longertimefromreferralto accessurgeryevaluationor




useanA VF versusotherVA typesif female,ofolderage,
havinggreaterBMI, diabetes,peripheralvasculardis-
ease,or recurrentceHulitis/gangrene.In addition,coun-
trieswith agreaterprevalenceof diabetesin HD patients
hada significantlylowerpercentageof patientsusingan
A VF. 1 T o better assesssimilaritiesand differences
amongdifferentcountriesin thefie1dof dialysisaccess,
we summarizedin Table 1 informationderivedfrom
differentstudies.1,4-8
It appearsthat specific country-re1atedand
facility-re1atedfactorshave a major influencein the
choiceofdialysisaccessoAccordingto ourideaIapproach
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Table 1 United States, Canada, Japan, and Europe: Similarities and Differences in Chronic Kidney Disease Patients
and in Clinical Care USA





Mortality r te for dialysi atients (%)
20.749.75 116.3
Transplants/pmp
57 63 .3<3 71 30.1.50
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4***6 *7 7 )** 8****
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e dialysis (%)
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e e (temporaryor unneled (%)
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NA, not available;pmp, per millionpopulation;BMI, Body Mass Index;AVF, arteriovenousfistula;eve, centraivenaus catheter.
Dataderivedfrom references1,4,5,6,7,8.
to advancedchronickidney disease(CKD) treatment




As we canseefrom Table 1,]ar,anhasthe best
prevalenceof AVF andverygoodsurvivalrates,butvery
low peritonealdialysis(PD) and transplantrates.Ger-
manyhasthelowestprevalenceof CVC in Europe,but
their performancein PD is the worst. Canada and
Table 2 Ideai Treatment of End-Stage Renal Disease
and Approach to Vascular Access
Whenglomerularfiltration ratefalls below 30mL/min (CKD
stage4) consider:
Preemptive transplant (no dialysis aeeess)
Pian dialysis aeeess (PD eatheter or AV aeeess)
Choiceof dialysis
Peritoneal dialysis flrst ehoice (at least 40% of ineident
patients)
Pian vaseularaeeess in seleeted patients, based on the
probabilityof transfer to hemodialysis
Hemodialysis seeond ehoiee; prevalent patients should ideally
have the following aeeess distribution:
AV fistula (70-90%)
AV graft 110-30%)
Tunneled internaijugular eatheter (5-15%)
Transplantafterstartingdialysis
Remember to preserve the (right)femoral/ iliaeveins to avoid
vaseular eomplieations at the time of kidney transplant
CKD, chronic kidneydisease; PD, peritonealdialysis;AV, arteriove-
nous
Swedenhavethe best PD rate amongthe countries
considered,but they have a very high prevalenceof
CVC. The United Stateshas the besttransplantrate,
butdoesnot farewell in PD andin vascularaccess(low
AVF), aswell asin survivalfor dialysispatients,despite
thefactthatit hasexcellentdoctorswithwell-recognized
publications,who haveaccessto solidgrantsfor high-
qualityinitiatives,like the Fistula First Initiative9and








(removal, replacement,and declot), vascular access
hospitalizations(for mechanicalcomplication,infection,
andsepsis)arealsoavailable.Suchdatawill certainlybe
useful in evaluatingthe effectsof the Fistula First
Initiative.
Why do Italian patientshavea high prevalence
of AVF? We believethat the main reasonis the fact
thatwhenthefirst dialysisunitswereopened,difficul-
ties arosein finding dedicatedvascularsurgeonsand
givingadequatepriority to dialysisaccesssurgery.In a
ratheruniqueway, nephrologists,who in somecases
had a surgicalbackgroundas urologistsor transplant
surgeons,startedperformingvascularaccesssurgery,
creating a situation where time from diagnosis of
ESRD to accesssurgerywas kept at the minimum
and the nephrologist-surgeonknew the problems
linked to accessuse,especiallycannulationissues.In
addition, the presenceof a National Health System
alIowedtime1yreferralfrom thegeneraIpractitionerto
the nephrologist.In some way, a primitive dialysis
accessteamwas alreadyin action,alI of it inside the
samerenalunitoThen, the figureof the nephrologist-
surgeongrewandin somecasesreachedhigh leve1sof
skilI, while severaldedicatedvascularand transplant
surgeonssolved the most difficult casesof vascular
accesscreation and revision, becomingsecond-Ievel
speciaIizedaccesssurgeonswith great experience.12
Interestingly,becausein Italy only certifiedradiolog-
ists canwork with x-ray machines,vascularinterven-
tional nephrologydid not deve10pwith the sameease;
therefore,most renal units developeda collabora-
tion with an interventionalradiologist,with the ex-
ception of colar Doppler ultrasonography-guided. l 13anglOpasty.
Why so manycathetersin Canada?Canadahas
a nationalhealth system,but the patternof vascular
accessdistributionis muchdifferentfrom Italy.This is
in striking contrastwith the excellentpenetrationof
the PD technique,which maybe favoredby patients
when theylive far awayfrom a HD unitoTwo recent
studies addressedthis problem.14.15Mende1ssohn
etaI14anaIyzeddatafromtheDOPPS study,reporting
that eventhough 85%of Canadianpatientshadbeen
seenby a nephrologistfar morethan1 monthprior to
startingdialysis,CVC usewas 33% in prevalentpa-
tients and 70% in incident patients,cont\:ilryto the
preferencesof Canadiandialysisclinic medicaIdirec-
torsoA possible reason far this discrepancyis the
Iengthof time from referraluntii permanentvascular
accesscreation(61.7dayscomparedwith 29.4daysin
Europe or 16 daysin the United States).In turn, this
longerde1aytime maybe a consequenceof the lower
numberof accesssurgeonsin Canadacomparedwith
the United Statesand someEuropeancountries.In a
situationsimilarto that facedby Italian nephrologists,
Canadiansdid not havethe opportunityto startsur-
gicai activity in vascularaccess,while it is common
practicefar a nephrologistto inserta tunneledcathe-
ter. Graham et al15found a significantinfluenceof
duration of HD on the type of accessoIn patients
within 6 monthsof HD initiation, therewas a very
high prevalenceof CVC use (75%), but as dialysis
vintage increased,the prevalenceof CVC use de-
creasedprogressively,reaching a low of 21.3% in
patientsafter5 yearsof HD. System/resourcelimita-
tions accountedfar the highestpercentageof factors
influencingthe choiceof CVC as HD accesswithin
thefirst6 monthsofHD (54.8%),comparedwith only
8.6%of factorsinfluencingaccesschoicein patientson
HD beyond5 years.This institutionhas a dedicated
dialysisaccessteamandallocatedoperatingroomtime
far accesscreation;however,therearea limited num-
berof accesssurgeonsavaiIable.
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Nonetheless,only 10.5%of patientswith CVC
were awaitingA VF ereation,revision,or maturation;
28.2% of patientswith system/resourceIimitations
influencingCVC choicewere either awaitingassess-
men! far peritoneaIdiaIysis,undecidedaboutmodality
choiCe, or awaiting transplant.Vascular issues ac-
countedfar the majorityof factorsinfluencingCVC
use (47.1%of patients),whereaspoor cardiacstatus
influenceddecisionmaking in 8.8%of patients.The
authorsconcludedthatpatient-specificfactors(vascular
factorsandmedicaIcontraindications)arethepredom-




vasc).16An analysisof 12,342open and endovascular
HD accessoperationsperformedbetween1987 and
2006wasundertaken.The medianageofpatientshaving
their first surgerysignificantlyincreasedfrom 56 to 68
during the first decade,then remainedstable.The
frequencyof diabetesincreasedfrom 12 to 32%.The






Although outcomesof vascularaccessare stilI
betterin Europe, a clearchangein clinical policiesis
taking pIace in the United States,with significant
resultsand an improvedprofile of vascularaccessuse.
The FistuiaFirst BreakthroughInitiative,whosegoalis
to ensurethat everypatient receivingHD has the
opportunity to have a native AVF as the optimal
vascularaccesswherefeasibIe,certainIycontributedto
suchanimprovement.8,17SimiIarly,theNetherlands,a
countrywith one of the IowestA VF ratesin Europe,
fosteredtheCIMINO initiative,18amulticenterguide-
Iines implementationprogram,which promoted an
increasein the numberof AVFs and a decreasein
untunneledcatheters.This was counterbalancedby





A DIAL YSIS ACCESS ALGORITHM
In keepingwith the idea of sharingexperiencesand




objective.19In theideaIworld (Table2), theimpending
renal failure diagnosisis proactivelymanagedwith a
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preemptiveliving donor kidney transplantor by the
timelycreationof the best(PD or HD) dialysisaccess
for the individuaIpatient.However,becauseof patient
denialand late considerationfor dialysisaccessplace-
ment,and sometimesbecauseof organizationalpitfalls
of nephrologicand surgical facilities, the reality is
plaguedby the fact that many patientsinitiate HD
with a dual lumen catheter.On the other hand, in
situationswheretimelyandaccurateeducationis given
to thepatientwith advancedCKD, asignificantlyhigher
numberof patients(40%)choosePD andonly a small




sentinga continuumof caretreatmentmodel of the
ESRD patient,where emphasisis placed on team
membersbeing in dose proximityand ideallyin the
sameclinic.2lThis allowstimelydecisionmakingfrom
the surgeon,the nephrologist,and the interventional
radiologist ("pit-stop approach").This concept also
implies clear and effectivecommunicationbetween
teammemberswith emphasison patientsafety,out-
come,andcomfort.
A dialysis accessshort- and long-term pIan
shouldbeupdatedon a regularbasis.With a proactive
approach,futureaccessproblemscanbeanticipatedand
addressedwith the overallgoal to avoiddialysisinter-
ruptions with temporarycentraI vein catheterand
associatedmorbidity. •.
HOW TO IMPROVE THE OUTCOME OF
DIAL YSIS ACCESS
Two seeminglysimple measureswould dramatically
improvethe outcomeof future dialysisaccess:early
referralandveinpreservation.Other factorsthatwould
promoteahigherprevalenceof nativeA VFs aretheuse
of microsurgery;extensiveuse of vesselmappingto
identif)rsuitablevesselsfor surgeryandthepr~senceof







in longer dialysis sessionsto keep dialysiseffective,
might alsobe a reasonwhy Europeanscanmaintaina
failing accessfor enoughtime to avoid the use of a
catheterwhilepreparinga newaccesso
Early Referral
Early referralto a nephrologistandto anaccessurgeon
for evaluationincreasesthe likelihood for placing a
nativeveinAVF andavoidingmorbidityfromatempo-
rary catheterplacement.22,23Indeed, startingdialysis
with apermanentA V accessis associatedwith improved
survivalof the accessitself, comparedwith patients
whoseA VF or A ve hasbeenplacedafterthe startof
dialysis.However, it should be kept in mind that
DOPPS I datashowedthatmost(55%)of the 46%of
U.S. patientsstartingdialysiswith avenouscatheterwas
seenby a nephrologistmore than 30 daysprior to
ESRD. Similarly, the problem of incident patients
startingdialysiswithoutapermanentaccessplaceddur-
ing CKD wasalsorelevantin Europeanpatients:56%of
themhadseenanephrologistmorethan30daysprior to
ESRD.3 Therefore,both in Europe and in the United
States,the situationcould be improvedwith a better
understandingof factors determiningthe lack of a




venous(IV) lines in potentialdialysisaccessveinsfor
AVF placementalsoincreasesthechancesfor nativevein
A VF. There is muchabuseof potentialA VF veinsfrom
IV linesandblooddraws.Only thedorsalaspectof the
handshouldbeallowedforvenousbloodaccessoPatients
undergoingHD can have blood draws done during
dialysistreatmentopreserveveins.PICC lines(periph-
erallyinsertedcentraIcatheters)must not be usedin
patientswith a futuredialysisneed,andcertainlynot in




termpatency,asreportedin the mostdifficult dialysis
population,children.24It impliesthe useof a surgical
microscope,microsurgicalinstruments,prophylactic
hemostasis,and no-touch surgery. Using this ap-
proach,Bourquelotet al25 reportedthe outcomesof
dialysisA V accessmicrosurgeryin 380 children: the
ratio AVF/AVe was 93%/7%and the creationof a
distaIA VF waspossiblein 78% of the children.The
immediatepatencyratewas96%andonly 10%of AVF
failed to mature.Remarkably,the 24-month patency
rate was 85% in distaI radial-cephalicAVF, 72% in
brachial-basilicAVF, 47% in brachial-cephalicAVF,
while A ve patencywas only 5%. The French expe-
riencemay be difficult to duplicatein different set-
tings, but the excellentresults reported with this
approachshould be seriously considerednow that
patient characteristicsare deterioratingand an in-
creasednumber of cathetersis being used in most
countries.
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Table 3 Goals of the Dialysis Access Team: Moving
from Crisis Management to Proactive/lnteractive
Planning




"Add-on" - ev ni g cas 2De icated proc dure rooms
3. Delays are the rule
3lays rare
4 Turnaround time
4.T rnaround time 2-6 hours
24 hours - we ks 5.
os h gh 5t - 20-50% less
6
Admissio co mo 6rare
7
Overu e of cath t r 7atheters rare
8
Mi s d trea en s 8eldom miss d tr atment
9
Pr to hi h failure rate 9. Success rate high (93-99%)
10.
No rel abl databa e 10. Close follow-up/database
11.
Lack f l ship 1 Clear line of command
159 HD patientswith matureAVFs whetheradding
accessblood flow surveillanceto clinical monitoring
(combinedwith e1ectivestenosisrepair)reducesthrom-
bosisandaccesslossrates.Theyfoundthataddingaccess
blood flow surveillanceto clinicalmonitoringis associ-
atedwith a betterdetectionand e1ectivetreatmentof
stenosis,a 73% reduction in thrombosisrate, 86%
reductionin CVC placements,65%reductionof access
loss, with a concomitantreductionof global access-
relatedcosts,althoughthe cumulativeaccesspatency
was only extendedin the first 3 yearsafter fistula
maturation.Thus, accessbloodflow surveillance,when
coupled with preemptiveintervention, reduces the
thrombosisratein A VF, suggestingthatthe functional
accesslife canbeprolonged.








Such an approachwasfirst described~1Oyears
ago.30,31Beckeretaeodemonstratedthatbyimplement-
ing a vascularaccesscarepathway,emphasizingcoordi-











Vesse1mappingis of paramountimportancein planning
andobtaininga successfulvascularaccess.26A pertinent
patienthistoryandphysicalexaminationareimportant
firststepsin assessingthecourseof action,bothprior to
accessplacementand when evaluatingan established
accesswith problems.These basic evaluationsdirect
decisionson moreexpensiveandofteninvasivetesting.
A carefullyperformedhistory and physicalexamwill
yie1dproper patient se1ectionfor the most optimal
dialysismodalityandsiteof accessplacement.A perti-





searchfor veinsin both upperextremitiestartingwith
the forearmcephalicandbasilicveins.Vascularexami-
nation must assessboth the arterialand the venous
system,throughinspectionandpalpation.Visibleveins
are markedwith an indelible pen to guide Doppler
ultrasoundexamination(DUE), which is oftenusedto
confirmor correcttheinitial impressionbasedonhistory




examination.The qualityof the DUE is operatorde-
pendent.Ideally,thesurgeonshouldbepresct'ltto direct
the sequenceof examinationstepsand markthe skin,
documentingvesse1size, intendedsurgerysites, and
anatomicvariations.The specificfeaturesassessedur-
ing DUE of thevenoussystem,thearterialsystem,and
of dialysisaccessgraftscan be found in our previous
publication.26DUE canalsobeusedtoassessbloodflow
problemsassociatedwith establishedHD accessoIt will
confirmtheclinicaldiagnosisanddirectthetreatmentin
themajorityof cases.In amorecomplexaccessituation,
invasiveimagingtechnologysuch as a fistulogramis
warranted.DUE and IV contrastfistulogramare-not
competitivebut complementary.In most instances,






AVF surveillancefor stenosis,but whetherit maybe
beneficial and cost-effectiveis controversia1.27Access
blood flow measurementallowsan accurateidentifica-
tionofA V accessesatriskof failure,with anaccessblood
flowlessthan700to 1000mLimin and/orareductionin
flow morethan25%asoptimalpredictorsfor stenosis.
Access blood flow less than 400 mL/min suggests
incipient thrombosis.Recently,Tessitoreet aes eval-
uatedin a 5-yearcontrolled,nonrandomizedstudyon









diatetechnicalsuccessrateof graftdeclotsfrom 48 to
69%;e1ectiveplacementof AVG evolvedfrom a 3-day
inpatienthospitalizationto a large1youtpatientproce-
dure;surgicalcomplicationsof new AV graft surgery
decreasedfrom 25% to 11%; aggressivedetectionand
correctionof graft stenosisdecreasedthe incidenceof
graft thrombosisby 60%;andtheproportionof native
A VF constructionin new dialysispatientsincreased
from 33 to 69%. This study also confirmsthat an
integratedmultidisciplinaryapproachcanreducesurgi-
cal complicationsof accesssurgeryand decreaseaccess
failures,with a concomitantdecreasein hospitalization
for accessproceduresanda substantialcostsaving.
Subsequently,the DOPPS I studyalsopointed
out that an importantaspectof incidentHD patients
careis the processand organizationalstructureof the
referralnetworkfor placingvascularaccesses.3A fast
processof lessthan2 weeksfrom timeof referraluntil
accessplacementwasassociatedwith a 1.8-foldhigher
like1ihoodof newESRD patientsbeginningHD with a
02
permanentvascularaccessoMore recently,Flu et alJ










Arso, higher primary and secondarypatency was













and dialysis accessmanagementshould give similar







plansfor futureintervention,if necessary.An Australian
group33recentlyconfirmedtheeffectivenessofintroduc-
ing a dialysisaccesscoordinatorin therenalunit. They
demonstratedthat aftera situationalanalysisshowed
pooroverallcoordinationof surgicalwaitinglists,multi-
facetedintervention,including the introductionof a
vascularaccessnursecoordinatorand an algorithmto
prioritizesurgery,significantlyincreasedtheproportion
of patientsstartingHD therapywith anA VF from56to
75%,_witha concomitant40% reductionin catheter-
days.
Improving Surgeon Education and Training in
Dialysis Access Surgery
More datafromtheDOPPS alIowsomeconsiderations
on the issueof appropriatesurgicaltrainingin dialysis
l 34 Th d' ..accessp acement. e stu y alm was to mvestlgate
whetherintensityof surgicaltraininginfluencestypeof
vascularaccessplacedand A VF survival.Prospective
datafrom 12 countriesin the DOPPS wereanalyzed;
outcomesof interestweretypeof vascularaccessin use
(AVF versusAVG) atstudyentryandtimefromplace-
ment until primaryand secondaryaccessfailures,as




where.SignificantpredictorsofA VF versusA VG place-
mentincludednumberof A VF placedduringtraining
and degreeof emphasison vascularaccesscreation
duringtraining.Risk of primaryfistulafailurewas34%
lowerwhenplacedby surgeonswho created25 or more
(versuslessthan25) AVFs duringtraining.Therefore,
the authorsconcludedthat surgicaltrainingis key to
both fistulaplacementand survival,yet D.S. surgical
programsseemto pIacelessemphasison fistulacreation
thanthosein othercountries,underscoringthe impor-
tanceof enhancingsurgicaltrainingin A VF creation.34
Improving Cannulation Skills
One importantissueis the timing of cannulationafter
A VF surgery.Rayneret al35showedthat cannulation
before14 daysof A VF life wasassociatedwith a 2.1-
fold increasedriskof subsequentA VF failurecompared
withAVF cannulatedafter14days,whilenosignificant
differencein A VF failurewasseenfor A VF usedin 15
to 28 dayscomparedwith 43 to 84 days.Accordingly,
AVF ideallyshouldbeleft to maturefor atleast14days
beforefìrst cannulation.Another relevantissueis can-
nulation technique,specifìcallythe potential advan-
tages of the buttonhole versus the standardrope-
laddertechnique.36The buttonholetechnique,cannu-
lationof exactlythesamesite,offerstheadvantageof an
easycannulationprocedure.However, it can be used
only in native fìstulas and cannulationis preferably
executedby a "single-sticker."A comparisonof the
two techniques in 33 self-cannulatinghome HD
patientswith a nativearteriovenousfìstulawasunder-
taken,prospectivelyobservingfor 18monthscannulat-




this was especiallyfavorablein patientswith a short
fìstulavein.Reportedcannulationpaindid not change
signifìcantly.The incidenceof bad sticks decreased
signifìcantly,aswell astimeof compressionafterneedie
removal, without increasedincidence of bleeding.
Three patientsdevelopeda Iocaiskin infectionof their
buttonhole during the study, which determineda
changein thedisinfectionroutineprior to cannuiation.
Thus, the buttonholemethodseemsto improvecan-
nuiatingeaseavoidingthepossibieformationof aneur-
ysms, but precautionshave to be taken to prevent
infectious complications.Indeed, Doss et ae7 also
suggestedthat the infectionratewith the buttonhole
methodof needieinsertionmaybeunderestimated.
Improving Infection Rates
The vascularaccesssite is the most commonsite for
infectionin HD patients,andaccess iteinfectionsare
particularlyimportantbecausetheycancauselossof the
vascularaccessand disseminatedbacteremia;they also
accountfor r--; 15% of deathsin diaIysispatients.The
primaryrisk factorfor accessinfectionis theaccesstype,
with CVC havingthe highestrisk,Ave intermediate,
andAVF the Iowestrisk of infection.The incidenceof
vascularaccessrelatedinfectionsis 1.3to 7.2/100patient










when consideringIocai infectionsresultswere similar
(1.34 versus 1.43/100 patient months, respectively),
whereassystemicinfections differed markedIy (0.19
versus1.78/100patientmonths).In tunneledcatheters,
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thedifferencein therateof systemicinfectionswas0.76/
100patientmonthsin Piedmontversus4.84/100patient
monthsin theUnited States.This differencemightbe
dueto moreaccurateCVC handlingin Italian dialysis
units, where the openingand closureof a CVC are
usuallyperformedasepticallyby two operators,and at
leastoneof themis a certifìednurse.
CONCLUSIONS
Vascularaccesscarein diaIysispatientsfrom different
countriesis characterizedby similar issues,although
with differentmagnitude.Obesity,of epidemicpropor-
tions in the United States,is aiso a growingprobIem
globally,which could causemorediffìcultiesin native
A VF creation.The sameconsiderationappliesto type2
diabetes,whichis agrowingprobIemaswell.Peripheral
vasculardiseaseappearsto be a previouslyunderesti-
matedindependentpredictorof CVC use.
Creation of dedicateddiaIysisaccessteams,in-
cludinga vascularaccesscoordinator,is in our view a
fundamentaistepin improvingvascularaccesscare.
Socialissues,systemandresourcelimitations,and
patient-specifìcfactors (vascularfactors and medicaI
contraindications)may influencedecision making in
thechoiceofA V accessversusCVC. Thus, it is possible




Important differencesstill exist amongEurope
and the United States,as demonstratedby the recent
A VF DAC Study,39which showedthat in theUnited
States20to 50%of fìstulasdonotmatureadequatelyfor
use,and that earlyAVF failure is a majorbarrierto
increasingfìstuiaprevalence,proiongingcatheteruse.
SuchfìguresraisedsurpriseamongEuropeannephrolo-
. d d' l . 40glStSan laYSlSaccessurgeons.
The possibilitythatfactorsdifferentfrompatients
characteristicsandsurgicalskillsareimportantin deter-
mining outcomesis Iikely, and it might expIainthe
apparentcontradictionofESRD practices(kidneytrans-
piant,peritonealdialysis,patternsof vascularaccessuse
in HD), wheresomecountriesexcelin one areaand
scorepoorlyin another.We join manyotherphysicians-
researchersin advocatingmore randomized triais
and appropriateepidemioiogicaistudies to improve
evidence-basedcare of diaIysis patients and their
vascularaccesso
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